AbuDhabiPR.com, Online Press Release from Abu Dhabi and Al Ain
 
Medicine, Laboratory & Treatment(Healthcare & Medicine)
Filter PR by
  
Mubadala Acquires KELIX bio to further Advance UAE's Life Sciences Ecosystem and expand its footprint in the sector
 
Mubadala Acquires KELIX bio to further Advance UAE's Life Sciences Ecosystem and expand its footprint in the sector
  • Mubadala supporting UAE's vision to become a global leader in the life sciences sector.
  • The acquisition of KELIX bio will reinforce the UAE's biopharma ecosystem and increase Mubadala's presence regionally and globally.

United Arab Emirates, 25 March 2024: – Mubadala Investment Company PJSC (Mubadala), an Abu Dhabi sovereign investor, has entered into a definitive agreement to acquire KELIX bio, a specialty pharmaceutical business focused on delivering complex generics across emerging markets, to further strengthen the development of the UAE's life sciences ecosystem, position the UAE as a global leader in the life sciences sector and to support the diversification of the economy in the UAE.

KELIX bio was incepted in November 2020, and has since, acquired manufacturing businesses in India, Egypt, Malta and Morocco successfully commercializing a broad range of both oral and injectable formulations covering diverse therapy areas including diabetes, oncology, cardiology, and central nervous systems.

The acquisition is set to boost the UAE's global standing in life sciences. With Kelix bio specializing in relevant therapy areas and a leadership team experienced in successful buy-and-build strategies globally, the move aligns with Mubadala's goal to position the UAE prominently in the global life sciences sector.

Dr. Bakheet Al Katheeri, Chief Executive Officer of Mubadala's UAE Investments Platform, said: 'In line with our role as a responsible investor, today's acquisition is testament to the role Mubadala continues to play in accelerating the nation's economic diversification through our portfolio companies and national champions.'

He added: 'This partnership marks a key milestone in further advancing Mubadala's position in the life sciences sector, to deliver important long-term socio-economic returns for our nation including improved healthcare, drug security, job creation and GDP impact.'

Ismail Ali Abdulla, Head of UAE Clusters, at Mubadala's UAE Investments Platform said: 'At Mubadala, we are deeply committed to enhancing the well-being of our communities through strategic investments that address critical health care needs. By amplifying our domestic capabilities in producing essential medications via Kelix bio, our goal is to significantly empower the UAE's healthcare infrastructure, ensuring wider access to life-saving treatments for all citizens. This investment is a testament to our dedication as a responsible investor, emphasizing our commitment to investing in solutions that address the world's most pressing challenges.'

Hocine Sidi-Said, co-founder, and Chief Executive Officer at KELIX bio commented: 'We are immensely grateful to our previous shareholders for their faith in our vision and for supporting a fast-paced acquisition program since inception. With Mubadala's acquisition of KELIX bio, we embark into an exciting journey that promises to deliver not only economic returns but also cause a durable societal impact in the United Arab Emirates. We are excited to augment the manufacturing capabilities of the nation and drive an innovation agenda in diabetes, oncology, and biologics to name a few.'

The UAE has historically witnessed a high incidence of non-communicable diseases such as cardiovascular disorders, cancer, and diabetes. Yet the nation relies on pharmaceutical imports to meet the needs of patients and healthcare professionals alike. Mubadala's 100% acquisition of KELIX bio is a strategic investment to advance the UAE's national life sciences capabilities by fostering innovation and manufacturing partnerships that will further enhance pharmaceutical capabilities regionally. The agreements build on Mubadala's efforts to establish an Abu Dhabi based national pharma champion, which will enhance the UAE's pharma infrastructure, address the nation's most prevalent diseases, reduce healthcare expenditure, strengthen the UAE's drug security and set another milestone towards a resilient, knowledge-based economy.

Prior to Mubadala's acquisition, KELIX bio was held by a consortium of investors including Development Partners International (DPI), British International Investment (BII), the UK's development finance institution and impact investor, and the European Bank for Reconstruction and Development (EBRD).

The transaction's completion is subject to customary regulatory approvals.

Posted by : Abu Dhabi and Al Ain PR Network Editorial Team
Viewed 966 times
PR Category : Healthcare & Medicine
Posted on : Monday, March 25, 2024  12:25:00 PM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AbuDhabiPR.com.
Previous Story : MEDCARE WOMEN & CHILDREN HOSPITAL leads the way in advanced ...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Catrice Launches Limited Edition About Tonight Collection for Ramadan 2024 [24979-Views]
SHEGLAM Unveils Exclusive Ramadan ‘Lunar & Stellar Box Set', across GCC countries. [23102-Views]
2023 Safest Year for Flying By Several Parameters [21525-Views]
Progress Report: Sustainability, Digitalization and Safety in Air Cargo [20398-Views]
F-16 Block 70 Jets Set Off on Historic Ferry Flight to Bahrain: A New Era in Air Defense [20281-Views]
Eid Gift Guide – Fragrance Edition [19568-Views]
Al Haramain Group shares its business growth by hosting UAE's largest Iftar for 5,000 people as it e... [15789-Views]
Watches & Wonders 2024 Unico: Hublot's Manufacture Calibre [15444-Views]
TCL Unveils World's Largest QD-Mini LED TV in Dubai [13974-Views]
Response Plus Holding Net Profit surges 68% to AED 49.39 million during 2023 [13747-Views]
Bremont introduces a new generation of its Supermarine diving watch series [12825-Views]
TAQA and JERA to develop Industrial Steam and Electricity Cogeneration Plant for Saudi Aramco Total ... [8922-Views]
SKIN111 inaugurates state-of-the-art 3000 sq. ft medical centre & aesthetics centre in Nakheel Mall... [7873-Views]
Khabib's Official Training Gloves Will Be Sold at Tooba Charity Auction in Dubai [7285-Views]
Xiaomi 14 Ultra Makes a Big Entrance in the UAE for the First Time [6570-Views]
Old Doha Port Joins the Dubai International Boat Show for the Second Year in a Row and Enters into a... [5730-Views]
Hotpack Global MD emerges Founding VC of Paper and Tissue Business Group at Dubai Chamber of Commerc... [5392-Views]
Make your Vishukkani last forever Tanishq Launches Exclusive Vishu Collection [4806-Views]
Cigna Healthcare Organizes Health Checks for Hundreds of Workers. [4748-Views]
Stay Hydrated This Ramadan with Rubicon's Organic Coconut Water [4464-Views]
 
RSS Facebook Twitter LinkedDin AbuDhabiPR.com on Instagram
 
Top Sections
 
Top Stories